Pharmafile Logo
Pharmafocus logo
Advanced Search

Medical Communications

Showing 15 posts of 6402 posts found.

Stand Up To Cancer announces four teams dedicated to increasing diversity in clinical trials

February 9, 2023 Medical Communications

Stand Up To Cancer (SU2C) has announced four teams that will focus on increasing diversity in early phase cancer clinical …
News

FDA grants RMAT designation for Mesoblast’s chronic low back pain treatment

February 9, 2023 Medical Communications

Mesoblast Ltd, an Australian regenerative medicine company leading in allogeneic cellular medicines for inflammatory diseases, announced that its treatment for …
News

Scottish biotech aims to cure common cold

February 8, 2023 Medical Communications

Scottish biotech company ScotBio has announced that it has seen “promising initial results” from its attempts to extract a cure …
News

AstraZeneca’s Forxiga approved in EU for chronic heart failure

February 7, 2023 Medical Communications

AstraZeneca has announced that its drug, Forxiga, has been approved in the EU for the treatment of symptomatic chronic heart …
News

Genentech shares positive results from global phase 3 trials for crovalimab in PNH

February 7, 2023 Medical Communications

Following the global COMMODORE 2 study, Genentech has announced positive data for crovalimab in treating patients with paroxysmal nocturnal haemoglobinuria …
News

Boston Scientific fined $42m over patent infringement

February 6, 2023 Medical Communications

A five-year legal battle between Boston Scientific and TissueGen has culminated in a $42m fine, which Boston Scientific must pay …
News

Drug-resistant bacteria found in eye drops has infected 55 people in 12 states

February 3, 2023 Medical Communications

A strongly drug-resistant bacteria has been found in multiple brands of artificial tears eyedrops; the most commonly reported was EzriCare …
News

DrugBAN AI expected to reduce costs and speed up drug discovery

February 3, 2023 Medical Communications

In a collaboration between Sheffield University and pharma giant, AstraZeneca, a new AI has been developed which could help deliver …
News

Genoscience Pharma received Orphan Drug Designation for hepatocellular carcinoma drug

February 3, 2023 Medical Communications

French clinical-stage biotech company Genoscience has received FDA Orphan Drug Designation (ODD) for its lead candidate ezurpimtrostat. OOD qualifies the …
News

FDA approves Axonics’ neurostimulator

February 1, 2023 Medical Communications

US-based medtech company Axonics have received FDA approval for their fourth-generation, rechargeable sacral neuromodulation system for the treatment of chronic …
News

Amgen launches Amjevita biosimilar on US market

January 31, 2023 Medical Communications

Amgen’s Amjevita (adalimumab-atto) has just launched on the US market, meaning it becomes the first biosimilar to reference the blockbuster …
News

Johnson & Johnson subsidiary loses US bankruptcy bid

January 31, 2023 Medical Communications

A US federal appeals court in Philadelphia has denied pharma giant Johnson & Johnson’s (J&J) subsidiary’s bankruptcy petition, which aimed …
News

Pfizer denies purposely mutating COVID-19 virus

January 30, 2023 Medical Communications

Big Pharma company Pfizer has publicly denied allegations that it is deliberately mutating the COVID-19 virus in order to develop …
News

FDA suggests individual risk assessments for blood donations to secure US blood supply

January 30, 2023 Medical Communications

The FDA has announced that it is suggesting a change from the time-based deferrals for blood donation to an individual …
News

Researchers develop test to predict Alzheimer’s disease years before diagnosis

January 30, 2023 Medical Communications

Researchers at King’s College London’s Institute of Psychiatry, Psychology & Neuroscience (IoPPN) have developed a blood test which can potentially …
News
The Gateway to Local Adoption Series

Latest content

STADA and Bio-Thera’s Gotenfia receives positive CHMP opinion for autoimmune diseases

December 18, 2025

Norgine enters exclusive licensing agreement with Vir Biotechnology

December 18, 2025

Incyclix appoints Kimberly Blackwell to Board of Directors

December 17, 2025

Hansa Biopharma appoints Max Sakajja as Vice President, General Manager Europe and International

December 17, 2025

GSK’s Exdensur receives MHRA approval for asthma and rhinosinusitis

December 16, 2025